Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial
| Title: | Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial |
|---|---|
| Authors: | Wu, JingAff1, Aff2, Aff3; Zhang, ShilongAff1, Aff2; Yu, ShanAff1, Aff2; An, GuoAff4, Aff5; Wang, YiAff6; Yu, YiyiAff1, Aff2; Liang, LiAff1, Aff2; Wang, YanAff1, Aff2; Xu, XiaojingAff1, Aff2; Xiong, YanShiAff4, Aff5; Shao, DiAff4; Shi, ZhunAff7; Li, NannanAff4, Aff7, Aff8; Wang, JingyuanAff1, Aff2; Jin, DaweiAff4, Aff5, IDs41467024531094_cor15; Liu, TianshuAff1, Aff2, IDs41467024531094_cor16; Cui, YuehongAff1, Aff2, IDs41467024531094_cor17 |
| Source: | Nature Communications. 15(1) |
| Database: | Springer Nature Journals |